Nektar Therapeutics NKTR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's total liabilities?
- Nektar Therapeutics (NKTR) reported total liabilities of $187.06M in Q1 2026.
- How has Nektar Therapeutics's total liabilities changed year-over-year?
- Nektar Therapeutics's total liabilities decreased by 22.9% year-over-year, from $242.5M to $187.06M.
- What is the long-term trend for Nektar Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Nektar Therapeutics's total liabilities has grown at a -16.2% compound annual growth rate (CAGR), from $461.47M to $190.57M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.